See every side of every news story
Published loading...Updated

The Global Market for Paclitaxel Injections Presents an $11.17 Billion Revenue Opportunity by 2029 – Analysis of Key Players Pfizer, BMS, Fresenius Kabi Oncology, Abbott Labs, and Viatris Among Others

Summary by dailyguardian.ca
Dublin, March 27, 2025 (GLOBE NEWSWIRE) — The “Paclitaxel Injection Market Report 2025″has been added to ResearchAndMarkets.com’s offering. This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. The paclitaxel injection market size has grown rapid…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

dailyguardian.ca broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.